Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular basis for the treatment of renal cell carcinoma.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Jan 2010

Suárez Cristina, Morales Rafael, Muñoz Eva, Rodón Jordi, Valverde Claudia M, Carles Joan

Abstract excerpt

Renal cell carcinoma (RCC) is a heterogeneous malignancy whose incidence rate has notably increased in recent years without any evident reason. Traditionally, RCC has been resistant to classic treatments (chemotherapy, radiotherapy and hormonal therapy), with only a small percentage of patients b...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Renal Cell
Share to Drug Delivery Systems
Share to Intracellular Signaling Peptides and Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Protein Serine-Threonine Kinases

Share to Syndrome

Share to TOR Serine-Threonine Kinases

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 20080466
DOI: 10.1007/s12094-010-0461-4

Genes

VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20080466-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular basis for the treatment of renal cell carcinoma.PMID 20080466Read ↗

Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Semantic proximity Read ↗

Molecular biology of renal cell carcinoma.Semantic proximity Read ↗

Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic TargetsSemantic proximity Read ↗

Signaling pathways in renal cell carcinoma.Semantic proximity Read ↗

Papillary renal cell carcinoma: A review of the current therapeutic landscape.Semantic proximity Read ↗

Current updates and future perspectives on the management of renal cell carcinoma.Semantic proximity Read ↗

Kidney cancer pathology in the new context of targeted therapy.Semantic proximity Read ↗

Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the LiteratureSemantic proximity Read ↗

Renal Cell Carcinoma in von Hippel–Lindau Disease—From Tumor Genetics to Novel Therapeutic StrategiesSemantic proximity Read ↗

Treatment strategies for clear cell renal cell carcinoma: Past, present and futureSemantic proximity Read ↗

Oncotargets in Different Renal Cancer SubtypesSemantic proximity Read ↗

Genomics of Renal Cell Cancer: The Biology Behind and the Therapy AheadSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.